Clear Harbor Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Clear Harbor Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-3,075	Closed	-$277K	–	448
2024 Q4	$277K	Hold	3,075	–	–	0.02%	319
2024 Q3	$304K	Buy	3,075 +60	+2%	+$5.89K	0.02%	295
2024 Q2	$280K	Hold	3,015	–	–	0.02%	298
2024 Q1	$286K	Sell	3,015 -197	-6%	-$18.3K	0.03%	298
2023 Q4	$287K	Sell	3,212 -1,135	-26%	-$84.3K	0.03%	285
2023 Q3	$317K	Buy	4,347 +134	+3%	+$10.7K	0.03%	260
2023 Q2	$351K	Buy	4,213 +975	+30%	+$81.5K	0.03%	258
2023 Q1	$247K	Sell	3,238 -25	-0.8%	-$2.07K	0.03%	317
2022 Q4	$271K	Sell	3,263 -1,100	-25%	-$89.1K	0.03%	275
2022 Q3	$346K	Sell	4,363 -1,127	-21%	-$95K	0.05%	243
2022 Q2	$408K	Buy	+5,490	New	+$412K	0.05%	235
2020 Q4	–	Sell	-110	Closed	-$12.3K	–	738
2020 Q3	$12.3K	Buy	+110	New	+$12.3K	﹤0.01%	561

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Clear Harbor Asset Management's XBI Position: Q1 2025 in Review

Clear Harbor Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2025, closing a stake of 3,075 shares — an estimated $277K sold.

Clear Harbor Asset Management first reported a position in XBI in Q3 2020 and held it in 12 quarters. The position peaked at $408K in Q2 2022. 685 funds tracked by Wall St. Rank hold XBI as of Q1 2025.

Clear Harbor Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2025 after selling out during the quarter.
Clear Harbor Asset Management sold 3,075 State Street SPDR S&P Biotech ETF shares in Q1 2025, an estimated $277K.
Clear Harbor Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and held it in 12 quarters.
Clear Harbor Asset Management's State Street SPDR S&P Biotech ETF position peaked at $408K in Q2 2022.
685 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2025.

Based on Clear Harbor Asset Management's 13F filing for Q1 2025, filed 15 May 2025.